| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | | | UNI - EN REPORT No | 43 | / | 2016 | | | |
| | Date of issue: | 2016-05-10 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Notification | |
| | Official market - legal basis | | | | | | |
| | Inne uregulowania | |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | The Board of Directors of SOPHARMA AD _the “Company"_ hereby informs that the Board of Directors of Sopharma AD authorized the executive director of the company to enter into a contract for the sale of the shareholding of Sopharma AD in the capital of Ivanchich and Sons, Serbia. The transaction was concluded on May 9th, 2016 in Belgrade, Serbia. The parameters of the transaction are subject to confidentiality clauses in the interest of the all parties. Sopharma AD will continue its activities on the Serbian market through its daughter company Sopharma Trading AD. | |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | | current report 43 ivancic ENG | |
